BE899184A - Emulsion liquide pour transfusion - Google Patents

Emulsion liquide pour transfusion

Info

Publication number
BE899184A
BE899184A BE0/212584A BE212584A BE899184A BE 899184 A BE899184 A BE 899184A BE 0/212584 A BE0/212584 A BE 0/212584A BE 212584 A BE212584 A BE 212584A BE 899184 A BE899184 A BE 899184A
Authority
BE
Belgium
Prior art keywords
transfusion
liquid emulsion
composition
fatty acid
fatty acids
Prior art date
Application number
BE0/212584A
Other languages
English (en)
Inventor
T Wakabayashi
K Okamoto
A Kanazawa
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12724361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE899184(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of BE899184A publication Critical patent/BE899184A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne une émulsion liquide pour transfusion, améliorée. La préparation comprend un acide gras ayant 20 à 22 atomes de carbone ou un ester de l'acide gras ou un mélange d'au moins deux des acides gras et des esters, une huile végétale, un agent émulsifiant et de l'eau. Cette préparation est une émulsion liquide pour transfusion qui est bien équilibrée en composition d'acides gras et est valable au point de vue nutritif. En outre, elle possède une activité anticoagulante et une activité antiartériosclérose. Utilisation de cette composition comme supplément nutritif.
BE0/212584A 1983-03-18 1984-03-16 Emulsion liquide pour transfusion BE899184A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58045618A JPS59172416A (ja) 1983-03-18 1983-03-18 脂肪輸液

Publications (1)

Publication Number Publication Date
BE899184A true BE899184A (fr) 1984-07-16

Family

ID=12724361

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212584A BE899184A (fr) 1983-03-18 1984-03-16 Emulsion liquide pour transfusion

Country Status (7)

Country Link
US (1) US5034414A (fr)
JP (1) JPS59172416A (fr)
BE (1) BE899184A (fr)
DE (1) DE3409793A1 (fr)
FR (1) FR2542613B1 (fr)
GB (1) GB2139889B (fr)
SE (1) SE8401393L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028732A1 (fr) * 1993-06-07 1994-12-22 Ici Australia Operations Proprietary Limited Diminution de la perte d'humidite dans les matieres vegetales et animales

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142159B1 (fr) * 1983-11-17 1991-07-03 Opel, Helmut, Dr.med. Analgésiques et antiphlogistiques superficiels
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
DE3524788A1 (de) * 1985-07-11 1987-01-22 Lentia Gmbh Stabile, intravenoes applizierbare, waessrige fettemulsion und ein verfahren zu deren herstellung
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
GB2194700B (en) * 1986-08-28 1991-04-17 Stc Plc Optical repeaters
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
SE467861B (sv) * 1987-12-18 1992-09-28 Kabi Pharmacia Ab Emulsion foer parenteral administrering
US5244925A (en) * 1987-12-18 1993-09-14 Kabi Pharmacia Aktiebolag Emulsion for parenteral administration
GB2218904A (en) * 1988-05-27 1989-11-29 Renafield Limited Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
DE3903057A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur endotrachealen applikation, ihre herstellung und anwendung
DE3903056A1 (de) * 1989-02-02 1990-08-09 Braun Melsungen Ag Fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung
EP0435683A1 (fr) * 1989-12-29 1991-07-03 Ajinomoto Co., Inc. Nutriment
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
DE19501288A1 (de) * 1995-01-18 1996-07-25 Beiersdorf Ag Fettsäurederivate enthaltende Lotionen
PT762837E (pt) 1995-03-31 2002-07-31 Schur Jorg Peter Processo para melhorar a durabilidade e/ou estabilizacao de produtos degradaveis microbiologicamente
AU701736B2 (en) * 1995-11-28 1999-02-04 B. Braun Melsungen Ag Hydrolysis-optimized lipid emulsions and use thereof
EP0843972B1 (fr) * 1996-11-20 2002-07-31 N.V. Nutricia Composition nutritionnelle comprenant des corps gras pour le traitement du syndrome métabolique
DE19931185A1 (de) 1999-07-07 2001-01-18 Joerg Peter Schuer Verfahren zur Entkeimung von Luft
DE19940605A1 (de) 1999-08-27 2001-03-01 Joerg Peter Schuer Imprägnierungsverfahren
JP4388322B2 (ja) * 2003-07-31 2009-12-24 花王株式会社 アポリポプロテインｄ分解抑制剤
JP2009518424A (ja) * 2005-12-09 2009-05-07 ドラッグテック コーポレイション 必須脂肪酸乳剤の静脈投与
WO2010004982A1 (fr) * 2008-07-07 2010-01-14 持田製薬株式会社 Agent améliorant ou thérapeutique pour une dyslipidémie

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2819199A (en) * 1953-10-27 1958-01-07 Schenley Lab Inc Stable injectable fat emulsions and process of producing same
GB785387A (en) * 1954-09-16 1957-10-30 Upjohn Co Therapeutic fat products and the manufacture thereof
US2853419A (en) * 1956-09-07 1958-09-23 Merck & Co Inc Aqueous fat emulsions and process for preparing the same
US2972565A (en) * 1958-04-04 1961-02-21 Univ Tennessee Res Corp Fat composition
US3676472A (en) * 1969-07-28 1972-07-11 American Home Prod Certain linoleic and linolenic acid ester fractions of vegetable oils and derivatives thereof
JPS537492B2 (fr) * 1973-02-12 1978-03-18
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
JPS56122312A (en) * 1980-02-29 1981-09-25 Kagakuhin Kensa Kyokai Hepatic cholesterol-lowering agent (hepatic decholesterolizing agent)
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
DE3131460A1 (de) * 1981-08-08 1983-02-24 B. Braun Melsungen Ag, 3508 Melsungen Fettemsulsion fuer parenterale ernaehrung
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028732A1 (fr) * 1993-06-07 1994-12-22 Ici Australia Operations Proprietary Limited Diminution de la perte d'humidite dans les matieres vegetales et animales

Also Published As

Publication number Publication date
DE3409793A1 (de) 1984-09-20
GB2139889B (en) 1986-08-13
JPH0349890B2 (fr) 1991-07-31
SE8401393L (sv) 1984-09-19
US5034414A (en) 1991-07-23
FR2542613A1 (fr) 1984-09-21
GB8407140D0 (en) 1984-04-26
DE3409793C2 (fr) 1990-03-01
FR2542613B1 (fr) 1990-01-12
SE8401393D0 (sv) 1984-03-13
JPS59172416A (ja) 1984-09-29
GB2139889A (en) 1984-11-21

Similar Documents

Publication Publication Date Title
BE899184A (fr) Emulsion liquide pour transfusion
EP0321128B1 (fr) Compositions d'acide gras
Dyerberg et al. A hypothesis on the development of acute myocardial infarction in Greenlanders
US4780456A (en) Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity
Haas et al. Extraction, purification, and acetylation of human renin and the production of antirenin to human renin
EP1702515A3 (fr) Composition à base de corps gras ou d'huile
FR2405024A1 (fr) Compositions d'huiles vegetales contenant de la lecithine
RU93058424A (ru) Вещество для понижения высокого уровня холестерина в сыворотке крови и способ его получения
Cucuianu et al. Pseudocholinesterase in obese and hyperlipemic subjects
TNSN86094A1 (fr) Composition d'essence
EP0196085B1 (fr) Compositions à absorption améliorée contenant de l'ubidécarénone
TNSN05001A1 (fr) Methode de preparation d'esters d'hydroxytyrosol, les esters ainsi obtenus et leur utilisation
DK0456764T3 (da) Omega-3-fedtsyreholdig fedtemulsion til endotracheal indgift, fremstilling og anvendelse heraf
EP0210483A1 (fr) Composition de corps gras d'origine végétale pour usage cosmétique
Olcott et al. Selenomethionine as an antioxidant
SG27290G (en) Sebum secretion accelerator
Campbell et al. Plasma albumin as an acceptor of free fatty acids
CA2201162A1 (fr) Esters phosphoriques d'alkyl ou d'acyl dianhydro-1,4:3,6-d-glucitol, procede de preparation et utilisations
Vidláková et al. Relationship of serum antioxidative activity to tocopherol and serum inhibitor of lipid peroxidation
Renaud et al. Comparative beneficial effects on platelet functions and atherosclerosis of dietary linoleic and γ-linolenic acids in the rabbit
BE1002428A3 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation.
Erlanson-Albertsson The importance of the tyrosine residues in pancreatic colipase for its activity
BE901206A (fr) Emulsion pour transfusion.
CA2007770A1 (fr) Graisse a tartiner a faible teneur en calories et sans lacto-proteines ayant une teneur en matieres grasses de 20 a 60 % en poids et contenant de la gelatine et de l'amidon solubilise
EP0398409A3 (fr) Composition de corps gras

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20030331